Press release
Liraglutide And Semaglutide Global Market Analysis, Trends, Growth, Research And Forecast 2033
Liraglutide And Semaglutide Global Market Analysis
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=18400&type=smp
According to The Business Research Company's, The liraglutide and semaglutide market size has grown rapidly in recent years. It will grow from $13.65 billion in 2023 to $15.19 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to the increasing prevalence of diabetes, growing incidence of obesity-related diseases, growth in the number of clinical trials, growing investment in diabetes research and development, and rising demand for convenient treatment options.
The liraglutide and semaglutide market size is expected to see rapid growth in the next few years. It will grow to $23.54 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to rising adoption of GLP-1 receptor agonists, increasing healthcare expenditure, expansion of pharmaceutical company product portfolios, rising disposable incomes, rising geriatric population susceptible to diabetes. Major trends in the forecast period include the integration of digital health platforms, implementation of personalized dosing strategies, advancements in drug delivery technologies, development of biosimilar versions, and integration of artificial intelligence in treatment decision-making.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/liraglutide-and-semaglutide-global-market-report
Market Drivers and Trends:
The rising number of diabetic patients is expected to propel the growth of the liraglutide and semaglutide markets going forward. Diabetes is a chronic condition characterized by elevated blood sugar levels due to insulin resistance and insufficient insulin production in the body. The rising number of diabetic patients is due to sedentary lifestyles, poor dietary habits, and genetic predispositions. Liraglutide and semaglutide are essential in treating diabetic patients by offering effective management of blood glucose levels and reducing the risk of complications associated with diabetes. For instance, in July 2021, according to a report by the International Diabetes Federation, a Belgium-based national diabetes association, the total number of people living with diabetes is expected to increase to 643 million by 2030 and 783 million by 2045. Therefore, the rising number of diabetic patients drives the liraglutide and semaglutide markets.
Major companies operating in the liraglutide and semaglutide markets are developing anti-diabetic biosimilar drugs to enhance glucose control and reduce cardiovascular risks in diabetic patients. Anti-diabetic biosimilars are cost-effective, near-identical copies of original diabetes biologics intended to deliver the same health benefits as the original drugs. For instance, in January 2024, Glenmark Pharmaceuticals Ltd., an India-based pharmaceutical company, launched a biosimilar of the popular anti-diabetic drug, Liraglutide, for the first time in India. It is a biosimilar of Liraglutide, an anti-diabetic drug to improve glycemic control among adults with type 2 diabetes mellitus. This launch reduces daily therapy costs, significantly expanding access for more patients nationwide. Priced at approximately INR 100 for a standard 1.2 mg dose per day, this substantially reduces therapy costs by about 70% and requires a prescription for purchase.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Major Key Players of the Market:
Pfizer Inc., Merck & Co. Inc., Bristol-Myers Squibb, AstraZeneca, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Otsuka Holdings Co. Ltd., Sun Pharmaceutical Industries Ltd., Sumitomo Pharma Co. Ltd., Shionogi & Co. Ltd., Cadila Pharmaceuticals, Kyowa Kirin Co. Ltd., Dr. Reddy's Laboratories Ltd., Biocon, Glenmark Pharmaceuticals Ltd., Bachem, Zealand Pharma, Shenzhen JYMed Technology Co. Ltd., Incepta Pharmaceuticals Ltd.
Liraglutide And Semaglutide Market 2024 Key Insights:
• The liraglutide and semaglutide market size is expected to see rapid growth in the next few years. It will grow to $23.54 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%.
• Impact Of Rising Diabetic Patients On Liraglutide And Semaglutide Market
• Advancements In Anti Diabetic Drug Development
• North America was the largest region in the liraglutide and semaglutide market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/customise?id=18400&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liraglutide And Semaglutide Global Market Analysis, Trends, Growth, Research And Forecast 2033 here
News-ID: 3721493 • Views: …
More Releases from The Business research company
Analysis of Key Market Segments Influencing the Extraterrestrial Legal Systems M …
Exploring the Future of Extraterrestrial Legal Systems
As humanity advances its presence beyond Earth, the need for specialized legal frameworks governing activities in outer space is becoming increasingly critical. The extraterrestrial legal systems market is set to expand rapidly, driven by the complexities of managing property rights, regulatory compliance, and dispute resolution in off-world environments. Let's delve into the anticipated market value, key players, significant trends, and the main segments shaping…
Emerging Growth Trends Driving Expansion in the Explosion Proof Cabins Market
The explosion proof cabins market is set to experience significant growth over the coming years, driven by increasing industrial safety demands and technological advancements. This market's evolution is shaped by emerging materials, innovative designs, and expanding applications, which all contribute to the rising adoption of explosion-resistant cabins in hazardous environments.
Forecast of the Explosion Proof Cabins Market Size by 2030
The explosion proof cabins market is projected to reach a value of…
Market Structure, Emerging Trends, and Key Player Analysis of the Electronic Pay …
The electronic payload fairing separation system market is poised for impressive expansion as innovations and technological advancements continue to reshape space launch operations. This report delves into the anticipated market size, key players, emerging trends, and segment classifications, offering a comprehensive overview of this specialized aerospace sector.
Projected Market Size and Growth Trajectory for Electronic Payload Fairing Separation Systems
The market for electronic payload fairing separation systems is forecasted to achieve substantial…
Leading Companies Fueling Growth and Innovation in the Dual Mode Microwave Seeke …
The dual mode microwave seeker market is positioned for significant expansion over the coming years, driven by a range of technological advancements and increasing defense requirements. This segment plays a crucial role in modern warfare and missile guidance, with innovation and integration shaping its future trajectory. Let's explore the current market size, key drivers, major players, and segmentation of this specialized industry.
Projected Market Growth for the Dual Mode Microwave Seeker…
More Releases for Liraglutide
What Is Driving Global Liraglutide And Semaglutide Market Growth in 2025: The Ro …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Liraglutide And Semaglutide Market Size Growth Forecast: What to Expect by 2025?
The market encompassing liraglutide and semaglutide has experienced substantial expansion lately, projected to increase from a valuation of $15.19 billion in 2024 to $16.94 billion in 2025, reflecting an annual growth rate of 11.5% based on the…
Impact Of Diabetic Population Growth On The Liraglutide Market: Critical Driver …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Liraglutide Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for liraglutide has seen substantial growth in recent years. The market size, which is expected to be at $6.38 billion in 2024, is projected to inflate to $6.95 billion in 2025, with a Compound…
Rising Diabetes Prevalence Drives Growth in Liraglutide and Semaglutide Markets …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Liraglutide And Semaglutide Industry Market Size Be by 2025?
In recent times, the liraglutide and semaglutide market has seen quick and impressive growth. The growth is projected to continue, with the market size increasing from $15.19 billion in 2024 to an estimated $16.98 billion in 2025,…
Key Trend Reshaping the Liraglutide Market in 2025: Expansion Of Generic GLP-1 P …
What combination of drivers is leading to accelerated growth in the liraglutide market?
The increasing diabetic population is expected to propel the liraglutide market. Diabetes, particularly type 2, is on the rise due to factors like sedentary lifestyles, unhealthy diets, and obesity. Liraglutide, a drug that mimics the GLP-1 hormone to regulate blood sugar, plays a significant role in managing diabetes. In March 2023, the UK's NHS reported a rise in…
Key Trend Reshaping the Liraglutide Market in 2025: Expansion Of Generic GLP-1 P …
"What Are the Projections for the Size and Growth Rate of the Liraglutide Market?
The market for liraglutide has seen robust expansion in the past few years. The market is projected to escalate from $6.38 billion in 2024 to $6.95 billion in 2025, representing a compound annual growth rate (CAGR) of 9.0%. This surge during the historic period can be linked to the rising numbers of individuals being identified with type…
Liraglutide Market Analysis 2024: Trends, Growth Drivers, and Key Players
"Gain a competitive edge with up to 30% off in-depth market reports-uncover key trends, growth drivers, and forecasts today!
The new report published by The Business Research Company, titled Liraglutide Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the liraglutide…
